Alliqua Announces Transaction with Celgene

28-11-2013 Business Wire HealthComments (0)

Celgene Corp.Pharmaceutical

Alliqua signs a licensing agreement with Celgene Cellular Therapeutics to develop and market Biovance and Extracellular Matrix. Celgene invested $6M in ALQA. ALQA also raised $7M from other investors.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top